Curcumin

Curcumin is the primary bioactive polyphenol in turmeric (Curcuma longa), a flowering plant in the ginger family whose rhizome has been used as a culinary spice and in Ayurvedic and traditional Chinese medicine for centuries. Curcumin gives turmeric its characteristic yellow color and accounts for approximately 2–5% of dried turmeric root by weight. Commercial curcumin supplements typically contain a concentrated extract of curcuminoids — a mixture of curcumin and two related compounds (demethoxycurcumin and bisdemethoxycurcumin) — rather than whole turmeric root.¹

Curcumin has demonstrated anti-inflammatory, antioxidant, and other biological activities in laboratory and animal studies through multiple proposed mechanisms, including inhibition of NF-κB signaling, modulation of cytokine production, and inhibition of several enzymes associated with inflammation. Whether these effects translate into clinically meaningful outcomes in humans is substantially constrained by a fundamental pharmacokinetic problem: curcumin has extremely poor oral bioavailability. It is poorly absorbed from the gastrointestinal tract, rapidly metabolized and conjugated, and quickly eliminated. Standard curcumin supplementation produces very low plasma concentrations, which may limit the clinical applicability of in vitro and animal findings.¹

Various formulations have been developed to improve bioavailability, including curcumin combined with piperine (bioperine, derived from black pepper), phospholipid complexes (meriva), nanoparticle preparations, and liposomal forms. Piperine at 20 mg has been reported to increase curcumin bioavailability by approximately 2,000% in one study; this combination is common in supplements marketed specifically for absorption.

Curcumin supplements are most commonly used for joint health and osteoarthritis, general anti-inflammatory support, and digestive health. The NCCIH notes that turmeric has been studied for multiple conditions; however, despite its long history of use, there is insufficient evidence from clinical research to support the use of turmeric supplementation for most health conditions.¹

For osteoarthritis specifically, multiple small randomized controlled trials have shown modest reductions in pain and improvement in function compared to placebo; the evidence is more positive in this application than in others, though trial sizes are generally small, follow-up durations are short, and bioavailability of the studied formulations varied. For inflammatory conditions (rheumatoid arthritis, inflammatory bowel disease), results are mixed and generally preliminary. For cognitive health and prevention of Alzheimer's disease, clinical trial evidence is largely negative or null despite promising preclinical data.¹

Clinical trials have used a wide range of doses — from approximately 500 mg to 8,000 mg of curcumin or curcuminoids per day, in varying formulations — making it difficult to establish a consensus effective dose. Studies using enhanced bioavailability formulations (piperine-containing products, phospholipid complexes) have generally used lower doses because of improved absorption. No Tolerable Upper Intake Level has been established; doses up to 8,000 mg/day have been used in some studies without serious adverse events, though GI side effects increase at higher doses.¹

Oral, as capsules, tablets, soft gels, or powders.

Store in a cool, dry place away from direct light. Curcumin is light-sensitive; air- and moisture-tight containers preserve potency. Curcumin and turmeric will stain surfaces, clothing, and skin on contact.

Curcumin is generally considered safe at commonly studied doses, and turmeric root has a very long history of use as a food spice. Several considerations apply:¹

• Gallbladder disease: Turmeric stimulates bile production and contraction of the gallbladder. Individuals with gallstones or obstruction of the bile ducts should avoid high-dose curcumin supplements.
• Blood thinners: Curcumin may have antiplatelet and mild anticoagulant effects. Concurrent use with warfarin, aspirin, clopidogrel, or other anticoagulants or antiplatelets may increase bleeding risk.
• Piperine interactions: Many curcumin supplements contain piperine to enhance absorption. Piperine is also a CYP3A4 and P-glycoprotein inhibitor and can increase the bioavailability and serum concentrations of multiple medications metabolized by these pathways; individuals on multiple medications should discuss piperine-containing supplements with their pharmacist.
• Iron absorption: High-dose curcumin may chelate iron and reduce its absorption; iron-deficient individuals should be aware of this interaction.
• Liver injury: Rare cases of drug-induced liver injury (DILI) have been reported in association with curcumin supplement use; the causal relationship is not fully established but warrants awareness.
• Pregnancy: High-dose curcumin supplements are not recommended during pregnancy; turmeric as a culinary spice at typical culinary amounts is generally considered safe.